- Home
- ITRG vs ADAP Comparison
ITRG vs ADAP Comparison
Compare ITRG & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRG
- ADAP
- Stock Information
- Founded
- ITRG 1997
- ADAP 2008
- Country
- ITRG Canada
- ADAP United Kingdom
- Employees
- ITRG N/A
- ADAP N/A
- Industry
- ITRG Precious Metals
- ADAP Biotechnology: Pharmaceutical Preparations
- Sector
- ITRG Basic Materials
- ADAP Health Care
- Exchange
- ITRG Nasdaq
- ADAP Nasdaq
- Market Cap
- ITRG 156.9M
- ADAP 158.6M
- IPO Year
- ITRG N/A
- ADAP 2015
- Fundamental
- Price
- ITRG $1.15
- ADAP $0.56
- Analyst Decision
- ITRG Strong Buy
- ADAP Strong Buy
- Analyst Count
- ITRG 1
- ADAP 4
- Target Price
- ITRG $2.00
- ADAP $2.79
- AVG Volume (30 Days)
- ITRG 458.4K
- ADAP 623.5K
- Earning Date
- ITRG 03-26-2025
- ADAP 03-05-2025
- Dividend Yield
- ITRG N/A
- ADAP N/A
- EPS Growth
- ITRG N/A
- ADAP N/A
- EPS
- ITRG N/A
- ADAP N/A
- Revenue
- ITRG N/A
- ADAP $175,041,000.00
- Revenue This Year
- ITRG N/A
- ADAP $204.91
- Revenue Next Year
- ITRG $69.44
- ADAP N/A
- P/E Ratio
- ITRG N/A
- ADAP N/A
- Revenue Growth
- ITRG N/A
- ADAP 146.27
- 52 Week Low
- ITRG $0.64
- ADAP $0.53
- 52 Week High
- ITRG $1.28
- ADAP $2.05
- Technical
- Relative Strength Index (RSI)
- ITRG 55.92
- ADAP 40.12
- Support Level
- ITRG $1.14
- ADAP $0.55
- Resistance Level
- ITRG $1.20
- ADAP $0.61
- Average True Range (ATR)
- ITRG 0.07
- ADAP 0.03
- MACD
- ITRG -0.00
- ADAP -0.00
- Stochastic Oscillator
- ITRG 50.00
- ADAP 12.14
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of highly prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.